Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Axogen, Inc. - Common Stock
(NQ:
AXGN
)
44.02
-2.17 (-4.70%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Axogen, Inc. - Common Stock
< Previous
1
2
3
Next >
Axogen Inc. (NASDAQ:AXGN) Achieves a Perfect Technical Score and Strong Fundamental Growth
↗
June 20, 2026
Via
Chartmill
AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam
↗
May 14, 2026
AxoGen (NASDAQ:AXGN) President and CEO Michael Dale said the company’s growth strategy remains centered on developing the market for peripheral nerve repair, while recent reimbursement wins are...
Via
MarketBeat
Axogen (AXGN) Q3 2025 Earnings Transcript
↗
April 28, 2026
Axogen (AXGN) Q3 2025 Earnings Transcript
Via
The Motley Fool
Axogen (AXGN) Q1 2025 Earnings Transcript
↗
April 28, 2026
Axogen (AXGN) Q1 2025 Earnings Transcript
Via
The Motley Fool
Axogen Inc (NASDAQ:AXGN) Rallies on Q1 Revenue Beat and Raised 2026 Guidance
↗
April 28, 2026
Via
Chartmill
Axogen Inc (NASDAQ:AXGN) Reports Q4 2025 Revenue Growth but Misses Profit Estimates
↗
February 24, 2026
Via
Chartmill
Capricorn Fund Makes a Huge Bet on Nerve Repair With 687,000 Share Axogen (AXGN) Investment Worth $22.4 Million
↗
April 26, 2026
This healthcare firm develops nerve repair solutions for hospitals and specialists in the U.S. and select global markets.
Via
The Motley Fool
Topics
Regulatory Compliance
Axogen (AXGN) Q2 2025 Earnings Transcript
↗
April 22, 2026
Axogen (AXGN) Q2 2025 Earnings Transcript
Via
The Motley Fool
Axogen Insider Sale of 5,221 Shares Follows 20% Revenue Growth in 2025. Here's What to Know
↗
March 24, 2026
This surgical solutions provider for nerve repair reported a notable insider sale amid a year of strong share price gains.
Via
The Motley Fool
Topics
Regulatory Compliance
AXOGEN INC (NASDAQ:AXGN) Fits the Minervini Trend Template with Strong Growth Momentum
↗
February 17, 2026
Via
Chartmill
Earnings Scheduled For October 29, 2025
↗
October 29, 2025
Via
Benzinga
Why Is Axogen Stock Down 11% In Pre-Market Today?
↗
August 25, 2025
Via
Stocktwits
This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth
↗
March 21, 2026
This healthcare firm develops advanced surgical solutions for peripheral nerve repair, serving hospitals and specialists worldwide.
Via
The Motley Fool
Topics
Regulatory Compliance
Axogen (AXGN) Q4 2025 Earnings Call Transcript
↗
February 24, 2026
Axogen (AXGN) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
HighMark Wealth Management Buys 158,855 Shares of Axogen Stock
↗
February 24, 2026
This healthcare firm delivers surgical solutions for peripheral nerve repair, targeting specialized surgeons across U.S. and global markets.
Via
The Motley Fool
Topics
Regulatory Compliance
Axogen CEO Axed 25,000 Shares From His Direct Holdings
↗
January 14, 2026
The CEO of this innovative nerve regeneration company sold thousands of shares in December 2025, among multiple other insiders at the company who sold shares to close out that year.
Via
The Motley Fool
Topics
Regulatory Compliance
Gapping stocks in Thursday's session
↗
December 04, 2025
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via
Chartmill
AXGN Stock Rises Pre-Market After FDA Approves Nerve Repair Graft
↗
December 04, 2025
Axogen’s Avance is an acellular nerve scaffold for the treatment of adult and pediatric patients aged a month or older with sensory, mixed, and motor peripheral nerve discontinuities.
Via
Stocktwits
Topics
Government
Keep an eye on the top gainers and losers in Wednesday's session.
↗
October 29, 2025
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 29, 2025
Via
Benzinga
Caterpillar Posts Upbeat Q3 Results, Joins United Therapeutics, Centene, Fortive And Other Big Stocks Moving Higher On Wednesday
↗
October 29, 2025
Via
Benzinga
Axogen Inc (NASDAQ:AXGN) Surges on Strong Q3 2025 Earnings Beat and Raised Guidance
↗
October 29, 2025
Axogen (AXGN) stock surged after Q3 2025 earnings beat estimates. Revenue grew 23.5% to $60.1M, while adjusted EPS of $0.12 crushed forecasts. The company also raised its full-year guidance.
Via
Chartmill
Topics
Earnings
12 Health Care Stocks Moving In Monday's Intraday Session
↗
August 25, 2025
Via
Benzinga
Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday
↗
August 25, 2025
Via
Benzinga
FDA Pushes Back Axogen Avance Nerve Graft Decision By 3 Months
↗
August 25, 2025
FDA delays Axogen's Avance Nerve Graft BLA review to December 5, after new data submission, while the company raises its full-year revenue outlook.
Via
Benzinga
Why Axogen Stock, Up 76% Over The Last Two Months, Just Plummeted
↗
August 25, 2025
The FDA's move is largely procedural, says one analyst, but it adds incremental uncertainty.
Via
Investor's Business Daily
Which stocks are moving before the opening bell on Monday?
↗
August 25, 2025
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
August 25, 2025
Via
Benzinga
Axogen (AXGN) Q2 Revenue Jumps 18%
↗
August 05, 2025
Via
The Motley Fool
Axogen Inc (NASDAQ:AXGN) Surges 15.8% After Q2 2025 Earnings Beat and Raised Guidance
↗
August 05, 2025
Axogen Inc (AXGN) surpasses Q2 2025 estimates with strong revenue and EPS growth, raises full-year guidance, sparking a 15.8% pre-market stock surge.
Via
Chartmill
Topics
Earnings
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
